Nuvectis Pharma NVCT 深 沪
已收盘 07-17 16:00:00 美东时间
19.14
+0.540
+2.90%
华盛通- 最 高19.21
- 今 开18.30
- 成交量 33.10万股
- 最 低 18.0407
- 昨 收 18.60
- 总市值 6.03亿
- 52周最高 29.275
- 市盈率 静 --
- 换手率 1.05%
- 52周最低 5.55
- 委 比 50.56%
- 总股本 3152.55万
- 历史最高 29.275
- 量 比 1.57
- 振 幅 6.29%
- 历史最低 3.08
- 每 手 1
- 风险率 3.73%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 高盛上调AMD目标价从450美元升至640美元；伯恩斯坦上调阿斯麦目标价从1971美元升至2623美元
今日重点评级关注：Roth Capital：维持Nuvectis Pharma"买入"评级，目标价从20美元升至33美元；摩根士丹利：维持GXO Logistics"超配"评级，目标价从75美元升至78美元
07-07 11:34
Catalyst Watch: SpaceX initiations, Sun Valley Conference, PepsiCo earnings
Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Read more about the events that may impact stock prices next week. Monday - July 6 Vo...
07-04 03:00
Why AeroVironment Shares Are Trading Higher By Over 21%; Here Are 20 Stocks Moving Premarket
Shares of AeroVironment, Inc. (NASDAQ:AVAV) rose sharply in pre-market trading after the company reported better-than-expected financial results for the fourth quarter of fiscal 2026. AeroVironment guided for fiscal 2027 revenue of approximately $2.13 billion to $2.23 billion, versus estimates of $2...
06-30 18:10
Nuvectis Pharma（NVCT）完成稀释性二次公开发行后 盘前股价下跌16.75%
生物制药公司Nuvectis Pharma（股票代码：NVCT）完成500万股稀释性二次公开发行定价，发行价为每股20.00美元，较前一交易日28.53美元的收...
06-30 16:26
Nuvectis Pharma股票发行引发投资者强烈反对
纽维蒂斯制药（纳斯达克代码：NVCT）敲定1亿美元普通股公开发行定价，合计发售500万股普通股，每股定价20美元，预计总募资1亿美元，发行预计2026年7月1日...
06-30 12:51
Nuvectis Pharma shares slide 19% on pricing of $100M stock offering
Nuvectis Pharma (NVCT) had priced its underwritten public offering of 5M shares of its common stock at $20 per share, with expected gross proceeds of $100M, the company said Monday, sending shares dow...
06-30 12:09
Nuvectis Pharma启动拟进行的公开股票发行
生物医药公司Nuvectis Pharma（股票代码：NVCT）宣布启动由承销商担保的普通股公开发行，全部发行股份由公司自行发售。 关键条款与资金用途： 拟授...
06-30 10:35
Nuvectis Pharma prices 5 million-share offering at $20, raising $100 million
Nuvectis Pharma prices 5 million-share offering at $20, raising $100 million Nuvectis priced an underwritten public offering of 5,000,000 common shares at USD 20 per share. Gross proceeds expected at USD 100 million; closing targeted for about July 1, 2026. Underwriters hold a 30-day option to buy u
06-30 10:30
Nuvectis Pharma启动公开发行 股价大幅下跌
临床阶段生物制药企业Nuvectis Pharma Inc（纳斯达克代码：NVCT）宣布启动普通股承销公开发行后，该股周一盘后交易时段下跌20.5%。 本次发行...
06-30 04:23
Nuvectis Pharma announces public share offering to support drug programs
Nuvectis Pharma (NVCT) announced on Monday that it has launched an underwritten public offering of its common stock. The underwriters will have a 30-day option to purchase up to an additional 15% of t...
06-30 04:10
